Journal ID (nlm-ta): Front Pharmacol
Journal ID (iso-abbrev): Front Pharmacol
Journal ID (publisher-id): Front. Pharmacol.
Title:
Frontiers in Pharmacology
Publisher:
Frontiers Media S.A.
ISSN
(Electronic):
1663-9812
Publication date
(Electronic):
14
February
2019
Publication date Collection: 2019
Volume: 10
Electronic Location Identifier: 51
Affiliations
[1]
1Department of Inflammation Research, Amgen Inc. , Thousand Oaks, CA, United States
[2]
2Department of Therapeutic Discovery, Amgen Inc. , Regensburg, Germany
[3]
3Department of Therapeutic Discovery, Amgen Inc. , Thousand Oaks, CA, United States
[4]
4Department of Medicinal Chemistry, Amgen Inc. , Thousand Oaks, CA, United States
[5]
5Department of Inflammation Research, Amgen Inc. , Seattle, WA, United States
[6]
6Department of Comparative Biology and Safety Sciences, Amgen Inc. , Seattle, WA, United States
[7]
7Department of Comparative Biology and Safety Sciences, Amgen Inc. , Thousand Oaks, CA, United States
[8]
8Department of Comparative Biology and Safety Sciences, Amgen Inc. , South San Francisco, CA, United States
[9]
9Genome Analysis Unit, Amgen Inc. , South San Francisco, CA, United States
[10]
10Institut für Physiologie, Universität Regensburg , Regensburg, Germany
Author notes
Edited by: Heike Wulff, University of California, Davis, United States
Reviewed by: George Chandy, University of California, Irvine, United States; Peter
Bradding, University of Leicester, United Kingdom
†Present address: Katja Labitzke, Clariant Produkte (Deutschland) GmbH, Planegg, Germany,
Longbin Liu, CHDI Management, CHDI Foundation, Los Angeles, CA, United States, Anh
Leith, Department of Genome Sciences, University of Washington, Seattle, WA, United
States, Esther Trueblood, Seattle Genetics, Bothell, WA, United States, Kelly Hensley,
Seattle Genetics, Bothell, WA, United States, Teresa L. Born, Sartorius Stedim BioOutsource,
Cambridge, MA, United States, Alison Budelsky, Immunology Research, Lilly Research
Laboratories, San Diego, CA, United States, Dirk Smith, Insight BioConsulting, Bainbridge
Island, WA, United States, Kerstin Weikl, Assay.Works GmbH, Regensburg, Germany, Andreas
Hochheimer, ISAR Bioscience GmbH, Planegg, Germany, John K. Sullivan, PolestarBio
LLC, Newbury Park, CA, United States
This article was submitted to Respiratory Pharmacology, a section of the journal Frontiers
in Pharmacology
Article
DOI: 10.3389/fphar.2019.00051
PMC ID: 6382696
PubMed ID: 30837866
SO-VID: 2836610d-68db-4cf8-9895-c4261dee3f06
Copyright © Copyright © 2019 Miner, Labitzke, Liu, Wang, Henckels, Gaida, Elliott, Chen, Liu,
Leith, Trueblood, Hensley, Xia, Homann, Bennett, Fiorino, Whoriskey, Yu, Escobar,
Wong, Born, Budelsky, Comeau, Smith, Phillips, Johnston, McGivern, Weikl, Powers,
Kunzelmann, Mohn, Hochheimer and Sullivan.
License:
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Funded by: Amgen
10.13039/100002429